The Schedule of Pharmaceutical Benefits has been updated. New, Amended and Deleted items can be found on the Summary of Changes page.
The following updates have also been made to the PBS Website on the dates specified.
- Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 August 2026
- Ex-manufacturer price - 1 August 2026
- Formulary Allocations - 1 August 2026
- First New Brand Price Reductions - 1 August 2026
- Drugs subject to Price Disclosure - 1 August 2026
- Drug Tariff - 1 August 2026
- Standard Formula Preparations - 1 August 2026
- Container Prices - 1 August 2026
- Section 3 – Container Prices, Fees, Standard Packs and Prices for Ready Prepared Pharmaceutical Benefits - 1 August 2026
- Flow-on Price Reductions for Combination Items - 1 August 2026
- Anniversary Price Reductions - 1 August 2026
- Medicine Status Website - 1 August 2026
- Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents - 31 July 2026
- Ministerial Discretion to reduce or not apply Statutory Price Reductions - 30 July 2026
- Agenda for the November 2026 PBAC meeting - 22 July 2026
- Access to Medicines Working Group – 23 April 2026 - 22 July 2026
- New PBS listing for nitisinone (Orfadin®) for the treatment of hereditary tyrosinaemia type 1 - 21 July 2026
- PBAC Public Summary Documents – March 2026 meeting - 17 July 2026
- Drug Utilisation Sub-Committee (DUSC) Outcome Statement - 17 July 2026
- Launch and live webinar for PSA Code of Ethics for Pharmacists - 17 July 2026
- PBS and RPBS Date of Supply Data - 16 July 2026
- PBS Calendars - 14 July 2026
- Drug Utilisation Sub Committee (DUSC) - 13 July 2026